MyMD Pharmaceuticals | 10-Q: Quarterly report

SEC announcementMay 15 17:08 ET · Announcements

Why Tilray Brands Shares Are Trading Lower By Around 22%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Shares of Tilray Brands, Inc. (NASDAQ:TLRY) fell sharply during Tuesday's session after the company missed third-quarter estimates and said it no longer expects to generate positive adjusted free cas

BenzingaApr 9 13:12 ET

Molecular Templates, Acorda Therapeutics, MyMD Pharmaceuticals Among Healthcare Movers

Seeking AlphaApr 9 10:00 ET

MyMD Pharmaceuticals Filing From Late Monday Shows Co. Entered Omnibus Waiver And Amendment Agreement With Required Holders Under Previously Announced Securities Purchase Agreement

As previously disclosed, on February 21, 2023, MyMD Pharmaceuticals, Inc. (the "Company") entered into a Securities Purchase Agreement (the "Purchase Agreement") with certain accredited investors (the

BenzingaApr 9 09:30 ET

Wall Street Set to Open Slightly Higher as Investors Await Wednesday's Inflation Data

US stocks were set to open slightly higher in Tuesday's trading session as investors looked ahead to March inflation data and the FOMC March meeting minutes slated for release on Wednesday. The Dow Jo

MT NewswiresApr 9 09:18 ET

Investors Eye Wednesday Inflation Data as US Futures Tread Water Tuesday Pre-Bell

US stock futures were flat in Tuesday's premarket session ahead of a relatively subdued day on the economic calendar as investors looked ahead to inflation data and the Federal Reserve's March meeting

MT NewswiresApr 9 08:19 ET